SYFPEITHI: database for MHC ligands and peptide motifs (scientific article (publication date: November 1999))

cites work (P2860)

Q40627421	A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation
Q36547317	A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities.
Q91707881	A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
Q37000138	A Novel Peptide Binding Prediction Approach for HLA-DR Molecule Based on Sequence and Structural Information
Q33790313	A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Expe
Q59800431	A Review on T Cell Epitopes Identified Using Prediction and Cell-Mediated Immune Models for Mycobacterium tuberculosis and Bordetella pertussis
Q35850475	A Simple Proteomics-Based Approach to Identification of Immunodominant Antigens from a Complex Pathogen: Application to the CD4 T Cell Response against Human Herpesvirus 6B
Q27638477	A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex
Q52617409	A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell Epitopes.
Q34650335	A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosis
Q39260317	A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88
Q39122672	A combination of epitope prediction and molecular docking allows for good identification of MHC class I restricted T-cell epitopes
Q35842434	A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-104:01, SLA-204:01, and SLA-3*04:01.
Q35288793	A common minimal motif for the ligands of HLA-B*27 class I molecules
Q33247448	A community resource benchmarking predictions of peptide binding to MHC-I molecules
Q57794299	A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins
Q38658872	A computational pipeline to generate MHC binding motifs.
Q51965134	A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules.
Q46204546	A consensus strategy for combining HLA-DR binding algorithms
Q38967091	A distinct immunogenic region of glutamic acid decarboxylase 65 is naturally processed and presented by human islet cells to cytotoxic CD8 T cells.
Q28483765	A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice
Q37513302	A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition
Q36370375	A human minor histocompatibility antigen resulting from differential expression due to a gene deletion
Q51917689	A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes.
Q92025822	A large peptidome dataset improves HLA class I epitope prediction across most of the human population
Q39125208	A large-scale computational study of inhibitor risk in non-severe haemophilia A.
Q63804628	A library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patients
Q40331084	A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein
Q33396199	A mathematical framework for the selection of an optimal set of peptides for epitope-based vaccines
Q34413009	A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 2-model applications
Q30828102	A modular concept of HLA for comprehensive peptide binding prediction
Q30661546	A naturally processed rat major histocompatibility complex class I-associated viral peptide as target structure of borna disease virus-specific CD8+ T cells
Q36989923	A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes
Q40902210	A novel H2A-E+ transgenic model susceptible to human but not mouse thyroglobulin-induced autoimmune thyroiditis: identification of mouse pathogenic epitopes.
Q33239312	A novel method to identify and characterise peptide mimotopes of heat shock protein 70-associated antigens.
Q47829053	A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.
Q43234831	A novel predictive technique for the MHC class II peptide-binding interaction
Q30155102	A novel transport mechanism for MOMP in Chlamydophila pneumoniae and its putative role in immune-therapy
Q35565945	A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells
Q40887427	A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A24 and HLA-DRB111 alleles may be prognostic and predictive biomarkers for clinical benefit
Q36547962	A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach
Q51898173	A probabilistic meta-predictor for the MHC class II binding peptides.
Q36558535	A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity
Q40700636	A recyclable assay to analyze the NH(2)-terminal trimming of antigenic peptide precursors
Q43744603	A reverse vaccinology approach for the identification of potential vaccine candidates from Leishmania spp.
Q35429274	A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets
Q26747063	A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells
Q33326976	A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
Q90098354	A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice
Q48649314	A vaccine targeting mutant IDH1 induces antitumour immunity.
Q39289753	A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
Q36106408	AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
Q30392493	AIDS-protective HLA-B27/B57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz
Q34140322	Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity
Q51888426	Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers.
Q35645154	Accurate prediction of immunogenic T-cell epitopes from epitope sequences using the genetic algorithm-based ensemble learning
Q36964053	Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model
Q45868889	Activation of CFTR-specific T Cells in cystic fibrosis mice following gene transfer.
Q35850673	Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities
Q37042331	Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response
Q24634560	Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1
Q42176846	Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCR.
Q41533770	Advances in T-cell epitope engineering
Q37997825	Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities
Q34170130	Advances in the study of HLA-restricted epitope vaccines
Q37844500	Advances of bioinformatics tools applied in virus epitopes prediction.
Q47672626	Allergenicity Assessment of Transgenic Wheat Lines In Silico
Q37514725	Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study
Q37696017	Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses
Q40207805	Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis
Q92297076	Alternative mRNA splicing in cancer immunotherapy
Q28743226	Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires
Q27485470	Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for “Holes” in the T Cell Repertoire
Q53822443	Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells.
Q39185706	An Overview of Bioinformatics Tools and Resources in Allergy
Q34862104	An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide
Q37537073	An effective and effecient peptide binding prediction approach for a broad set of HLA-DR molecules based on ordered weighted averaging of binding pocket profiles.
Q41787921	An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform
Q37370515	An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.
Q40210664	An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8(+) T cells and antibody when expressed from modified vaccinia Ankara
Q30159852	An integrated machine learning system to computationally screen protein databases for protein binding peptide ligands
Q51969975	An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.
Q24810967	An ontology for immune epitopes: application to the design of a broad scope database of immune reactivities
Q46963588	Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm
Q36604367	Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry
Q46678222	Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals
Q47555471	Analysis of viral diversity for vaccine target discovery
Q21203715	AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data
Q47220965	Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes.
Q35927580	Antigen processing by macroautophagy for MHC presentation
Q34193262	Antigen processing by the proteasome
Q36176613	Antigen processing is predictable: From genes to T cell epitopes
Q37403114	Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
Q40447695	Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
Q38284692	Antigen-specific vaccines for cancer treatment
Q24644600	AntigenDB: an immunoinformatics database of pathogen antigens
Q35755292	Antigens of bacteria associated with periodontitis.
Q36664234	Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3' untranslated region of TRIT1.
Q45918640	Antitopes define preferential proteasomal cleavage site usage.
Q36155913	Antitumor cytotoxic T-cell response induced by a survivin peptide mimic
Q47663922	Are there HLA combinations typical supporting for or making resistant against aggressive and/or chronic periodontitis?
Q35048340	Aspects of cancer immunotherapy
Q52018428	Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women
Q90266059	Autoimmunity (or Not) in Atopic Dermatitis
Q33785039	Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes
Q53677823	Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.
Q47615055	Automatic sequence design of major histocompatibility complex class I binding peptides impairing CD8+ T cell recognition
Q37667281	Autophagy and Autophagy-Related Proteins in CNS Autoimmunity.
Q36471836	Autophagy and antigen presentation
Q36503156	Autophagy and antiviral immunity
Q37173279	Autophagy and viral neurovirulence
Q37510279	Autophagy as an emerging dimension to adaptive and innate immunity
Q37219526	Autophagy in CD4+ T-cell immunity and tolerance.
Q36406535	Autophagy in innate and adaptive immunity against intracellular pathogens.
Q26864841	Autophagy in innate recognition of pathogens and adaptive immunity
Q35632007	Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health
Q44850862	Autoreactive responses to an environmental factor. 2. Phthalate-induced anti-DNA specificity is downregulated by autoreactive cytotoxic T cells
Q40239641	BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes
Q47389306	BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma.
Q34265052	Bacterial antigens elicit T cell responses via adaptive and transitional immune recognition
Q21266599	Bcipep: a database of B-cell epitopes
Q38074902	Biochemical large-scale identification of MHC class I ligands
Q44573284	Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome
Q38044925	Bioinformatic databases and resources in the public domain to aid HLA research
Q37701117	Bioinformatic prediction of the epitopes of Echinococcus granulosus antigen 5.
Q26864876	Bioinformatics for cancer immunology and immunotherapy
Q36687906	Bioinformatics for study of autoimmunity
Q44396424	Bioinformatics identification of antigenic peptide: predicting the specificity of major MHC class I and II pathway players
Q48355191	Bonobos Maintain Immune System Diversity with Three Functional Types of MHC-B.
Q57114951	Breast cancer vaccination comes to age: impacts of bioinformatics
Q60300317	Broad CD8 T cell cross-recognition of distinct influenza A strains in humans
Q33930297	Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation
Q39032610	Building proteomic tool boxes to monitor MHC class I and class II peptides
Q48185876	CD4 and CD8 T lymphocyte interplay in controlling tumor growth
Q35129657	CD4+ T cell epitope identification: applications to allergy
Q33788075	CD4+ T cells play a dominant role in protection against New World leishmaniasis induced by vaccination with the P-4 amastigote antigen
Q37990213	CD4+ T-cell activation for immunotherapy of malignancies using Ii-Key/MHC class II epitope hybrid vaccines
Q30384608	CD4+ T-cell epitope prediction using antigen processing constraints
Q34111645	CD4+-T-cell responses generated during murine Salmonella enterica serovar Typhimurium infection are directed towards multiple epitopes within the natural antigen FliC
Q51327462	CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.
Q90610394	CD8+ Cytotoxic T Lymphocyte Responses and Viral Epitope Escape in Acute HIV-1 Infection
Q33942390	CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck
Q43843631	CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein
Q33305428	CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation
Q37358997	CD8+ T cells in type 1 diabetes
Q35871310	CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells
Q40010732	CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT.
Q42282904	CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells
Q44925388	CD8+ suppressor-mediated regulation of human CD4+ T cell responses to glutamic acid decarboxylase 65.
Q21263133	CED: a conformational epitope database
Q31010282	CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope
Q39533424	CTL recognition of a novel HLA-A*0201-binding peptide derived from glioblastoma multiforme tumor cells
Q36413180	CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
Q38209294	Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?
Q37148184	Cancer genome sequencing and its implications for personalized cancer vaccines
Q35948346	Candidate epitope identification using peptide property models: application to cancer immunotherapy
Q73832185	Cell mediated immune responses against human prion protein
Q35946943	Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins
Q36230842	Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?
Q24791721	Cellular responses to Plasmodium falciparum erythrocyte membrane protein-1: use of relatively conserved synthetic peptide pools to determine CD4 T cell responses in malaria-exposed individuals in Benin, West Africa
Q39215865	Characterization of Ewing sarcoma associated cancer/testis antigens
Q55028507	Characterization of a Trichinella spiralis putative serine protease. Study of its potential as sero-diagnostic tool.
Q40512504	Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes
Q39896760	Characterization of murine T-cell epitopes on mycobacterial DNA-binding protein 1 (MDP1) using DNA vaccination
Q47941525	Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients
Q40274683	Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice
Q31151209	Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity
Q40032484	Characterizing the Mycobacterium tuberculosis Rv2707 protein and determining its sequences which specifically bind to two human cell lines.
Q37864525	Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8+ T cell epitopes recognized by infection-primed T cells.
Q36365784	Citrullination only infrequently impacts peptide binding to HLA class II MHC
Q47998083	Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution
Q37864193	Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice
Q33414050	Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in Malaysia
Q33721633	Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method
Q46261095	Co-factor-independent phosphoglycerate mutase of Leishmania donovani modulates macrophage signalling and promotes T-cell repertoires bearing epitopes for both MHC-I and MHC-II.
Q39243560	Combinatorial chemistry by ant colony optimization.
Q31126784	Combinatorial peptide library methods for immunobiology research
Q37700567	Combined cytolytic effects of a vaccinia virus encoding a single chain trimer of MHC-I with a Tax-epitope and Tax-specific CTLs on HTLV-I-infected cells in a rat model.
Q34425066	Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens
Q33999284	Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.
Q22065493	Comparative Genomic Analysis of Chlamydia trachomatis Oculotropic and Genitotropic Strains
Q61709634	Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4−/− and CD8−/− DBA/1 mice defines qualitative roles of different T cell subsets
Q34256148	Comparing the similarity of different groups of bacteria to the human proteome
Q39005162	Comparison of experimental fine-mapping to in silico prediction results of HIV-1 epitopes reveals ongoing need for mapping experiments
Q40673830	Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides
Q44789283	Composition of the HLA-DR-associated human thymus peptidome.
Q27472881	Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities
Q36440605	Compromised central tolerance of ICA69 induces multiple organ autoimmunity.
Q38915682	Computational Resources for MHC Ligand Identification
Q45399910	Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential.
Q50933370	Computational approaches to identify common subunit vaccine candidates against bacterial meningitis.
Q38885361	Computational genomics tools for dissecting tumour-immune cell interactions
Q34687613	Computational immunology: The coming of age.
Q35948335	Computational methods for prediction of T-cell epitopes--a framework for modelling, testing, and applications
Q35583039	Computational tools for the study of allergens
Q26852825	Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates
Q34201227	Computer aided prediction and identification of potential epitopes in the receptor binding domain (RBD) of spike (S) glycoprotein of MERS-CoV.
Q34312517	Computer aided selection of candidate vaccine antigens
Q42638946	Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences
Q35041407	Concerted in vitro trimming of viral HLA-B27-restricted ligands by human ERAP1 and ERAP2 aminopeptidases
Q36499204	Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7
Q35927376	Conservation analysis of dengue virus T-cell epitope-based vaccine candidates using Peptide block entropy
Q64360303	Conserved peptide vaccine candidates containing multiple Ebola nucleoprotein epitopes display interactions with diverse HLA molecules
Q36339503	Constitutive and inflammatory immunopeptidome of pancreatic β-cells
Q33363387	Contamination of synthetic HuD protein spanning peptide pools with a CMV-encoded peptide
Q37313736	Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
Q57808143	Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome
Q42676309	Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
Q37075162	Coping with loss of perfection in the MHC class I peptide repertoire
Q35119641	Could TCR antagonism explain associations between MHC genes and disease?
Q55342452	Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B.
Q51072328	Crystal structure of a polypeptide's C-terminus in complex with the regulatory domain of ER aminopeptidase 1.
Q27640122	Crystal structures of two rat MHC class Ia (RT1-A) molecules that are associated differentially with peptide transporter alleles TAP-A and TAP-B
Q31048582	Curation of complex, context-dependent immunological data
Q64947848	Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design.
Q38953021	Current tools for predicting cancer-specific T cell immunity
Q87421678	Customized predictions of peptide-MHC binding and T-cell epitopes using EPIMHC
Q40550760	Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated Microspheres
Q34243434	Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
Q51912898	Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2.
Q34712758	Cytolytic T lymphocytes from HLA-B8+ donors frequently recognize the Hodgkin's lymphoma associated latent membrane protein 2 of Epstein Barr virus
Q34390499	Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging
Q36648360	Cytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumours
Q34353365	Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice
Q36591409	DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells
Q35826392	DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
Q37885288	DNA fusion vaccines enter the clinic.
Q37866631	DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model.
Q36154869	DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model
Q57027357	DNA prime-protein boost vaccine encoding HLA-A2, -A24 and -DR1 restricted epitopes of CaNA2 against visceral leishmaniasis
Q34127323	DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses
Q40086895	Dana-Farber repository for machine learning in immunology
Q38612613	Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity.
Q50955695	Deciphering complex patterns of class-I HLA-peptide cross-reactivity via hierarchical grouping.
Q61443414	DeepSeqPan, a novel deep convolutional neural network model for pan-specific class I HLA-peptide binding affinity prediction
Q35786206	Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules
Q78311457	Definition of permissible and immunogenic HLA antigens based on epitope analysis of the HLA specific antibodies produced in sensitized patients
Q51036610	Definition of supertypes for HLA molecules using clustering of specificity matrices.
Q77068420	Definition of the immunogenic HLA epitopes based on an epitope prediction algorithm
Q35939427	Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients
Q43657065	Dendritic cells presenting pyruvate kinase M1/M2 isozyme peptide can induce experimental allergic myositis in BALB/c mice
Q28475576	Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapy
Q37473978	Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma
Q43472318	Design and characterization of a chimeric multiepitope construct containing CfaB, heat-stable toxoid, CssA, CssB, and heat-labile toxin subunit B of enterotoxigenic Escherichia coli: a bioinformatic approach.
Q53637625	Design and use of conditional MHC class I ligands.
Q33746654	Design and utilization of epitope-based databases and predictive tools
Q43093883	Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules
Q53631492	Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition.
Q38820109	Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates
Q35058917	Designing of interferon-gamma inducing MHC class-II binders.
Q41874594	Designing string-of-beads vaccines with optimal spacers
Q38800011	Designing therapeutic cancer vaccines by mimicking viral infections
Q89210618	Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis
Q45888990	Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy
Q90576547	Developing neoantigen-targeted T cell-based treatments for solid tumors
Q36029171	Development of Acquired Immunity following Repeated Respiratory Syncytial Virus Infections in Cotton Rats
Q34358851	Development of a novel in silico docking simulation model for the fine HIV-1 cytotoxic T lymphocyte epitope mapping
Q37394695	Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer
Q44923495	Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.
Q33489506	Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen
Q38533017	Developments in cancer vaccines for hepatocellular carcinoma
Q52005389	Differences in maintenance of CD8+ and CD4+ bacteria‐specific effector‐memory T cell populations
Q42592117	Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis
Q38960204	Differential ion mobility spectrometry coupled to tandem mass spectrometry enables targeted leukemia antigen detection
Q44284826	Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling.
Q37192020	Dipeptides promote folding and peptide binding of MHC class I molecules
Q39768969	Direct antigen presentation by DC shapes the functional CD8(+) T-cell repertoire against the nuclear self-antigen La-SSB.
Q36689109	Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells
Q30361736	Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin
Q51945027	Direct prediction of T-cell epitopes using support vector machines with novel sequence encoding schemes.
Q27473483	Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide
Q38347244	Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!
Q34130833	Discovery of T cell antigens by high-throughput screening of synthetic minigene libraries
Q37322142	Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection
Q37456000	Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development
Q34093166	Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach
Q37276597	Discovery of novel targets for multi-epitope vaccines: screening of HIV-1 genomes using association rule mining
Q51991472	Discriminating self from nonself with short peptides from large proteomes.
Q36407362	Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses
Q39956342	Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure
Q38750956	Diverse HLA-I Peptide Repertoires of the APC Lines MUTZ3-Derived Immature and Mature Dendritic Cells and THP1-Derived Macrophages
Q36499325	Diversity and evolution of the rhoph1/clag multigene family of Plasmodium falciparum
Q33227607	Diversity in the acute CD8 T cell response to vaccinia virus in humans
Q34650773	Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells
Q36186533	Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?
Q37033008	Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?
Q51001482	Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.
Q34347732	Driving forces of proteasome-catalyzed peptide splicing in yeast and humans
Q42797684	Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease
Q43031528	Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients
Q34601454	Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak
Q26822893	Effects of Peptide on NK cell-mediated MHC I recognition
Q35214407	Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis.
Q39800428	Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a.
Q35083983	Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis
Q35100809	Emerging vaccine informatics
Q26781304	Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways
Q39424744	Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopes
Q30479692	Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection
Q34047191	Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)
Q40215247	Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide
Q45083568	Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide
Q51990458	Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.
Q36487452	Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells
Q33236277	EpiJen: a server for multistep T cell epitope prediction
Q39784947	EpiToolKit--a web server for computational immunomics
Q34486583	EpicCapo: epitope prediction using combined information of amino acid pairwise contact potentials and HLA-peptide contact site information.
Q35827003	Epitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte Epitopes
Q24802067	Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10
Q51894674	Epitope landscape in breast and colorectal cancer.
Q36062915	Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK
Q36620162	Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties
Q40266719	Epitopes rationally selected through computational analyses induce T-cell proliferation in mice and are recognized by serum from individuals infected with Schistosoma mansoni.
Q39920161	Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype
Q40511063	Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein
Q33325636	Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research
Q33393949	Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research
Q36909127	Evidence for positive selection in putative virulence factors within the Paracoccidioides brasiliensis species complex
Q33290217	Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1
Q50317337	Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.
Q40809435	Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells
Q34975513	Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.
Q47617870	Examination of possible structural constraints of MHC-binding peptides by assessment of their native structure within their source proteins.
Q35262045	Examining variable domain orientations in antigen receptors gives insight into TCR-like antibody design
Q54648290	Expansion of CD4 T cells expressing a highly restricted TCR structure specific for a single parasite epitope correlates with high pathology in murine schistosomiasis.
Q33850655	Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients
Q53647622	Experimental myositis inducible with transfer of dendritic cells presenting a skeletal muscle C protein-derived CD8 epitope peptide.
Q38913724	Exploration of peptides bound to MHC class I molecules in melanoma
Q38752281	Exploration of the BF2*15 major histocompatibility complex class I binding motif and identification of cytotoxic T lymphocyte epitopes from the H5N1 influenza virus nucleoprotein in chickens
Q40512928	Exploring peptide/MHC detachment processes using hierarchical natural move Monte Carlo.
Q45929502	Exploring the MHC-peptide matrix of central tolerance in the human thymus.
Q40821867	Exploring the unbinding of Leishmania (L.) amazonensis CPB derived-epitopes from H2 MHC class I proteins
Q33269889	Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
Q34777218	Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus
Q37066721	Extensive HLA class I allele promiscuity among viral CTL epitopes
Q24548447	FIMM, a database of functional molecular immunology: update 2002
Q33478350	FRED--a framework for T-cell epitope detection
Q87789748	FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity
Q37754754	Factors influencing immunodominance hierarchies in TCD8+ -mediated antiviral responses
Q33377255	Flanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pockets
Q36874759	Fowlpox-based survivin vaccination for malignant mesothelioma therapy
Q40801080	Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens
Q61759673	Functional expression of a bovine major histocompatibility complex class I gene in transgenic mice
Q33482103	Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation
Q49594989	Fundamentals and Methods for T- and B-Cell Epitope Prediction.
Q34023265	GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination
Q34221724	GPS-MBA: computational analysis of MHC class II epitopes in type 1 diabetes
Q47601200	Gapped sequence alignment using artificial neural networks: application to the MHC class I system.
Q52026288	Gender differences in HLA phenotype frequencies found in German patients with generalized aggressive periodontitis and chronic periodontitis.
Q50113046	Gene delivery by attenuated Salmonella typhimurium: comparing the efficacy of helper versus cytotoxic T cell priming in tumor vaccination.
Q33691683	Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma
Q24815448	Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method
Q38942201	Generation of cytotoxic T lymphocytes specific for native or modified peptides derived from the epidermal growth factor receptor pathway substrate 8 antigen
Q57221639	Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
Q36028231	Genetic aspects of immune-mediated adverse drug effects
Q33814247	Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphoma
Q28748331	Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate
Q51759998	Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis.
Q35648255	Genome-derived vaccines
Q37398991	Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4(+) T-cell responses to internal proteins, hemagglutinins, and neuraminidases
Q35030976	Genomics-based identification of self-ligands with T cell receptor-specific biological activity
Q39740215	Getting peptide vaccines to work: just a matter of quality control?
Q42416375	Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks
Q45730978	Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules
Q47317031	GradDock: Rapid Simulation and Tailored Ranking Functions for Peptide-MHC Class I Docking.
Q33857800	Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion
Q33754985	H-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8+ T lymphocytes can produce gamma interferon without cytotoxicity
Q51987940	HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.
Q37028039	HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients
Q24299045	HLA DR B104, 07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis
Q37414385	HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity
Q38819387	HLA class I binding prediction via convolutional neural networks
Q27324007	HLA class I molecular variation and peptide-binding properties suggest a model of joint divergent asymmetric selection
Q33315730	HLA class I supertypes: a revised and updated classification
Q36194073	HLA class I transgenic mice: development, utilisation and improvement
Q90425771	HLA class I-restricted T cell epitopes isolated and identified from myeloid leukemia cells
Q34655698	HLA class II peptide-binding and autoimmunity
Q38148779	HLA ligandome tumor antigen discovery for personalized vaccine approach
Q37116031	HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase
Q42598828	HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
Q47835567	HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses
Q38560231	HLA-B polymorphisms and intracellular assembly modes.
Q33911914	HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load
Q33918894	HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.
Q34341384	HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function
Q36303660	HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives
Q36737531	HLA-DR: molecular insights and vaccine design
Q38217357	HLA-binding properties of tumor neoepitopes in humans
Q39788447	HLaffy: estimating peptide affinities for Class-1 HLA molecules by learning position-specific pair potentials
Q39076137	HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo
Q36791906	HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype
Q40674982	Harnessing the cellular immune system to the gene-prediction cart
Q37735121	Hepatitis B splice-generated protein antibodies in Syrian chronic hepatitis B patients: incidence and significance
Q35857548	Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients
Q37174520	Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection
Q37275906	Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function
Q52005186	Heterozygote advantage fails to explain the high degree of polymorphism of the MHC.
Q39301397	High immunogenicity of the human leukocyte antigen peptidomes of melanoma tumor cells
Q33628719	High throughput T epitope mapping and vaccine development
Q93051749	High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity Predictions
Q36972511	High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopes
Q33995557	High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations
Q43483087	Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice
Q33322206	Hotspot Hunter: a computational system for large-scale screening and selection of candidate immunological hotspots in pathogen proteomes
Q26750788	How frequently are predicted peptides actually recognized by CD8 cells?
Q33293891	Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection
Q33302672	Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection
Q33321888	Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery.
Q41487863	Human Leukocyte Antigen (HLA)-DRB115:01 and HLA-DRB501:01 Present Complementary Peptide Repertoires
Q28251022	Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response
Q24289630	Human T cell responses to Japanese encephalitis virus in health and disease
Q33245126	Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
Q44315577	Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients.
Q39742082	Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice
Q57445880	Human population-based identification of CD4+ T-cell peptide epitope determinants
Q41839973	Human self-protein CD8+ T-cell epitopes are both positively and negatively selected
Q51820107	Humanization of Predicted T-Cell Epitopes Reduces the Immunogenicity of Chimeric Antibodies: New Evidence Supporting a Simple Method
Q42847212	IDR knowledge base for primary immunodeficiencies
Q38963058	Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06.
Q34509541	Identification and characterization of H-2d restricted CD4+ T cell epitopes on Lpp20 of Helicobacter pylori
Q35857723	Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus
Q28710385	Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells
Q39865703	Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes
Q30418879	Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE.
Q38462400	Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients
Q90628298	Identification of Antigenic Targets
Q45362381	Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy
Q40403892	Identification of B- and T-cell epitopes within the fibronectin-binding domain of the SfbI protein of Streptococcus pyogenes
Q64054729	Identification of CD4 and H-2K-restricted cytotoxic T lymphocyte epitopes on the human herpesvirus 6B glycoprotein Q1 protein
Q35078281	Identification of CD8+ cytotoxic T lymphocyte epitopes from porcine reproductive and respiratory syndrome virus matrix protein in BALB/c mice
Q34125106	Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes
Q36367674	Identification of Conserved Peptides Comprising Multiple T Cell Epitopes of Matrix 1 Protein in H1N1 Influenza Virus
Q35832185	Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma
Q92206244	Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models
Q37336046	Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes
Q51066151	Identification of HLA-A2-restricted immunogenic peptides derived from a xenogenic porcine major histocompatibility complex.
Q35210224	Identification of HLA-B27-restricted peptides in reactive arthritis and other spondyloarthropathies: computer algorithms and fluorescent activated cell sorting analysis as tools for hunting of HLA-B27-restricted chlamydial and autologous crossreacti
Q37707523	Identification of HLA‑A*1101‑restricted cytotoxic T lymphocyte epitopes derived from epidermal growth factor pathway substrate number 8.
Q35867348	Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice
Q28550337	Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis
Q38909633	Identification of Mycobacterium tuberculosis PPE68-specific HLA-A*0201-restricted epitopes for tuberculosis diagnosis
Q35411077	Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic mice
Q35549821	Identification of Novel Potential Vaccine Candidates against Tuberculosis Based on Reverse Vaccinology
Q36610286	Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
Q30717088	Identification of T helper cell-recognized epitopes in the chitinase of the filarial nematode Onchocerca volvulus
Q36870592	Identification of T-cell epitopes for cancer immunotherapy
Q59806946	Identification of a First Human Norovirus CD8 T Cell Epitope Restricted to HLA-A0201 Allele
Q50054503	Identification of a Novel CD8 T Cell Epitope Derived from Plasmodium berghei Protective Liver-Stage Antigen.
Q57285391	Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis
Q24649346	Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes
Q34508082	Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors
Q40585877	Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein
Q40439479	Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.
Q30951751	Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.
Q45728526	Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein
Q42153821	Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patients.
Q39727327	Identification of a novel peptide derived from the M-phase phosphoprotein 11 (MPP11) leukemic antigen recognized by human CD8+ cytotoxic T lymphocytes.
Q24673417	Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens
Q40417298	Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus
Q24645122	Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein
Q33315752	Identification of an HLA-A*0201-restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPT51 overlapping peptide screening
Q52349546	Identification of an HLA-A2-restricted CD147 epitope that can induce specific CTL cytotoxicity against drug resistant MCF-7/Adr cells.
Q39990744	Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A*2402-restricted cytotoxic T lymphocytes
Q33219527	Identification of an immunogenic EWS-FLI1-derived HLA-DR-restricted T helper cell epitope
Q36399462	Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames
Q34520629	Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis.
Q37545011	Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children
Q52043734	Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.
Q40436586	Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein
Q31080718	Identification of murine H2-Dd- and H2-Ab-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis
Q40540049	Identification of murine T-cell epitopes in Ebola virus nucleoprotein
Q44486249	Identification of murine T-cell epitopes on low-molecular-mass secretory proteins (CFP11, CFP17, and TB18.5) of Mycobacterium tuberculosis
Q43461527	Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction.
Q40884483	Identification of novel CD8+ T cell epitopes in human herpesvirus 6B U11 and U90.
Q39224992	Identification of novel HLA-A 0201-restricted cytotoxic T lymphocyte epitopes from Zinc Transporter 8.
Q36725757	Identification of novel IGRP epitopes targeted in type 1 diabetes patients.
Q39539865	Identification of promiscuous HLA-DR-restricted CD4⁺ T-cell epitopes on the cancer-testis antigen HCA587.
Q42218961	Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design
Q34243390	Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes
Q62555865	Identification of synthetic vaccine candidates against SARS CoV infection
Q24679680	Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.
Q39607014	Identification of the immunodominant H-2K(k)-restricted cytotoxic T-cell epitope in the Borna disease virus nucleoprotein
Q45887812	Identification of the immunodominant cytotoxic T-cell epitope of human alpha-1 antitrypsin.
Q45882310	Identification of the murine firefly luciferase-specific CD8 T-cell epitopes.
Q35604748	Identification of three novel CTL epitopes within nucleocapsid protein of Hantaan virus
Q34718188	Identification of tumour-associated T-cell epitopes for vaccine development
Q92611787	Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
Q34467405	Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
Q43102522	Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation
Q50057949	Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report.
Q40599136	Immune recognition of a human renal cancer antigen through post-translational protein splicing.
Q36296166	Immune surveillance of intracellular pathogens via autophagy
Q81538924	Immunization with hybrid recombinant Mycobacterium tuberculosis H37Rv proteins increases the TH1 cytokine response in mice following a pulmonary instillation of irradiated mycobacteria
Q30250980	ImmunoNodes - graphical development of complex immunoinformatics workflows
Q52365761	Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1.
Q37158031	Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum.
Q91636268	Immunogenicity and Immune Silence in Human Cancer
Q37046880	Immunogenicity of HLA-DR1 Restricted Peptides Derived from Leishmania major gp63 Using FVB/N-DR1 Transgenic Mouse Model
Q36509894	Immunogenicity of MHC Class I Peptides Derived from Leishmania mexicana Gp63 in HLA-A2.1 Transgenic (HHDII) and BALB/C Mouse Models
Q34546149	Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice
Q44842813	Immunogenicity of eight Mycobacterium avium subsp. paratuberculosis specific antigens in DNA vaccinated and Map infected mice
Q42217677	Immunogenicity of recombinant human bocavirus-1,2 VP2 gene virus-like particles in mice
Q49168236	Immunogenicity screening in protein drug development.
Q57556550	Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies
Q51534488	Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosis.
Q36304147	Immunoinformatics and epitope prediction in the age of genomic medicine
Q21145682	Immunoinformatics comes of age
Q37781086	Immunoinformatics: an integrated scenario
Q28241898	Immunoinformatics: current trends and future directions
Q37545001	Immunological characterization of a modified vaccinia virus Ankara vector expressing the human papillomavirus 16 E1 protein
Q40369476	Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization.
Q50979402	Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes.
Q38728603	Immunomics: a 21st century approach to vaccine development for complex pathogens
Q66679236	Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence
Q28238379	Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response
Q36133140	Immunotherapy for pancreatic cancer - science driving clinical progress
Q56927415	Impact of Leishmania donovani infection on the HLA I self peptide repertoire of human macrophages
Q37586592	Improved pan-specific MHC class I peptide-binding predictions using a novel representation of the MHC-binding cleft environment
Q45398545	Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus
Q33370669	Improving peptide-MHC class I binding prediction for unbalanced datasets
Q42910320	In Silico Design and Analysis of TGFαL3-SEB Fusion Protein as "a New Antitumor Agent" Candidate by Ligand-Targeted Superantigens Technique
Q36985387	In Silico Design of a Chimeric Protein Containing Antigenic Fragments of Helicobacter pylori; A Bioinformatic Approach.
Q42934914	In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B--a clue for vaccine development
Q100415799	In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli
Q35198753	In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.
Q55490730	In silico and ex vivo approaches indicate immune pressure on capsid and non-capsid regions of coxsackie B viruses in the human system.
Q36088477	In silico characterization of immunogenic epitopes presented by HLA-Cw*0401
Q90592477	In silico design of a T-cell epitope vaccine candidate for parasitic helminth infection
Q37858087	In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB.
Q37610312	In silico methods for predicting T-cell epitopes: Dr Jekyll or Mr Hyde?
Q48008312	In silico prediction of Leishmania major-specific CD8+ epitopes
Q90911275	In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine
Q84002630	In vitro and in vivo identification of a novel cytotoxic T lymphocyte epitope from Rv3425 of Mycobacterium tuberculosis
Q28541967	In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes
Q59356991	In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection
Q47550608	In-depth phylodynamics, evolutionary analysis and in silico predictions of universal epitopes of Influenza A subtypes and Influenza B viruses
Q77475273	Individuation of monoclonal anti-HPV16 E7 antibody linear peptide epitope by computational biology
Q36509692	Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein
Q40730694	Induction of Specific CD8 T Cells against Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches
Q31076623	Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Q33307523	Induction of human immunodeficiency virus (HIV-1) envelope specific cell-mediated immunity by a non-homologous synthetic peptide
Q36896712	Innate and adaptive immunity through autophagy
Q34056087	Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
Q37748492	Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses
Q37851048	Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands
Q42689269	Insights into amprenavir resistance in E35D HIV-1 protease mutation from molecular dynamics and binding free-energy calculations.
Q34429970	Integrated modeling of the major events in the MHC class I antigen processing pathway
Q31111568	Integrating epitope data into the emerging web of biomedical knowledge resources
Q34788108	Integrating peptides' sequence and energy of contact residues information improves prediction of peptide and HLA-I binding with unknown alleles
Q37859218	Interaction of allergens, major histocompatibility complex molecules, and T cell receptors: a 'ménage à trois' that opens new avenues for therapeutic intervention in type I allergy
Q34189720	Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes
Q30251957	Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.
Q34214158	Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?
Q95491344	Introduction
Q44142652	Involvement of CD91 and scavenger receptors in Hsp70-facilitated activation of human antigen-specific CD4+ memory T cells
Q44220785	Is fungal foot infection the initiating and maintaining cause of knee osteoarthritis?
Q37404522	Is the risk of multiple sclerosis related to the 'biography' of the immune system?
Q91971816	Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer
Q37434480	LAPTM4B-35 protein is a weak tumor-associated antigen candidate
Q40429655	Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma
Q45383350	Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis
Q24288783	Large scale characterization of the LC13 TCR and HLA-B8 structural landscape in reaction to 172 altered peptide ligands: a molecular dynamics simulation study
Q73401896	Large-scale analysis of HLA peptides presented by HLA-Cw4
Q59134452	Large-scale computational identification of HIV T-cell epitopes
Q40603434	Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
Q33304572	Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction
Q27472584	Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice
Q44252110	Lentiviral vector followed by protein immunisation breaks tolerance against the self-antigen Her1 and results in lung cancer immunotherapy
Q40156180	Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo.
Q33931811	Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells
Q50447093	Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens.
Q90101976	Ligandomes obtained from different HLA-class II-molecules are homologous for N- and C-terminal residues outside the peptide-binding cleft
Q51075893	Liposomes containing NY‑ESO‑1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccines.
Q36307488	Localization of CD8 T cell epitope within cardiac myosin heavy chain-α334-352 that induces autoimmune myocarditis in A/J mice
Q34789311	Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite.
Q57325915	Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses
Q42619783	Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox
Q48091147	Longevity of antibody and T-cell responses against outer membrane antigens of Orientia tsutsugamushi in scrub typhus patients.
Q37738467	Low level of HIV-1 evolution after transmission from mother to child
Q37636670	Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens
Q33757923	MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection
Q36088285	MHC Class II Binding Prediction by Molecular Docking
Q46459379	MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy
Q40746040	MHC I stabilizing potential of computer-designed octapeptides.
Q36266437	MHC class I alleles and their exploration of the antigen-processing machinery
Q52838605	MHC class I molecules exploit the low G+C content of pathogen genomes for enhanced presentation.
Q37452154	MHC class I-associated peptides derive from selective regions of the human genome
Q36381178	MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response
Q30388353	MHC class II epitope predictive algorithms.
Q41944422	MHC motif viewer
Q37790648	MHC presentation via autophagy and how viruses escape from it.
Q51938042	MHC-BPS: MHC-binder prediction server for identifying peptides of flexible lengths from sequence-derived physicochemical properties.
Q42629047	MHC-I prediction using a combination of T cell epitopes and MHC-I binding peptides
Q37696988	MHC-based detection of antigen-specific CD8+ T cell responses.
Q35911151	MHC-bound antigens and proteomics for novel target discovery.
Q33432313	MHCBN 4.0: A database of MHC/TAP binding peptides and T-cell epitopes
Q39804098	MHCPred: A server for quantitative prediction of peptide-MHC binding.
Q90552077	MHCquant: Automated and Reproducible Data Analysis for Immunopeptidomics
Q35914254	MODPROPEP: a program for knowledge-based modeling of protein-peptide complexes
Q24813031	MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides
Q91671018	Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors
Q26767472	Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection
Q37762296	Major histocompatibility complex class I binding predictions as a tool in epitope discovery.
Q36194241	Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias
Q34645213	Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design?
Q64910188	Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.
Q57178228	Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry
Q30002365	Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
Q39474621	Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells
Q36986531	Mass spectrometry and peptide-based vaccine development
Q92052807	Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics
Q24555754	Mate choice decisions of stickleback females predictably modified by MHC peptide ligands
Q39849181	Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture
Q35050403	Mechanisms of MHC class I-restricted antigen presentation
Q47191093	Membranal and blood-soluble HLA class II peptidome analyses using data-dependent and independent acquisition
Q36399737	Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients
Q33957612	MetaMHC: a meta approach to predict peptides binding to MHC molecules.
Q51554310	Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer.
Q33271867	Mimotope vaccines for cancer immunotherapy
Q30621114	Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Q48372980	Modeling the adaptive immune system: predictions and simulations.
Q43102307	Modeling the repertoire of true tumor-specific MHC I epitopes in a human tumor
Q36519420	Modeling the structure of bound peptide ligands to major histocompatibility complex
Q33635226	Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition
Q36690145	Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals
Q27469459	Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis
Q30589557	Molecular immunology databases and data repositories.
Q40953830	Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8(+) T-cell responses
Q43909373	Molecular modeling of class I and II alleles of the major histocompatibility complex in Salmo salar
Q34737266	Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells
Q39886235	Monitoring macroautophagy by major histocompatibility complex class II presentation of targeted antigens
Q42673280	Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome
Q36808693	More than one reason to rethink the use of peptides in vaccine design
Q34416487	Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus
Q33712291	Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
Q64079285	Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Q33702755	MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes
Q31022597	Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma
Q64097789	Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
Q37547268	Multipeptide vaccination in cancer patients.
Q34801834	Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes
Q36032150	Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor
Q24294775	Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells
Q42983683	Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51.
Q34122073	Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells
Q43560379	Mutation of Cys-67 alters the thermodynamic stability of the human leukocyte antigen HLA0-B*2705.
Q34734850	Mutation-specific control of BCR-ABL T315I positive leukemia with a recombinant yeast-based therapeutic vaccine in a murine model
Q64074701	Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8 T Cells and Evolve at the Population Level
Q35097333	Mycobacterium tuberculosis directs immunofocusing of CD8+ T cell responses despite vaccination
Q33504888	NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction
Q28743225	NNAlign: a web-based prediction method allowing non-expert end-user discovery of sequence motifs in quantitative peptide data
Q36406293	NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination
Q36637651	NY-ESO-1 immunotherapy for multiple myeloma
Q34388367	NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
Q36760435	Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy.
Q35575931	Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts
Q64087357	Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes
Q57209274	Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer
Q88716389	Nature of tumour rejection antigens in ovarian cancer
Q40211477	Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental
Q92137757	Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
Q34194564	Neonatal and maternal immunological responses to conserved epitopes within the DBL-gamma3 chondroitin sulfate A-binding domain of Plasmodium falciparum erythrocyte membrane protein 1.
Q33873269	NetCTLpan: pan-specific MHC class I pathway epitope predictions
Q36749382	NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11
Q34366463	NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure.
Q35869130	NetMHCpan, a method for MHC class I binding prediction beyond humans
Q28469279	NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence
Q36742441	NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets
Q47827615	NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery.
Q51083423	NetTepi: an integrated method for the prediction of T cell epitopes.
Q47693913	Neural models for predicting viral vaccine targets
Q48519025	Nomenclature and Serology of HLA Class I and Class II Alleles.
Q37611838	Noncanonical expression of a murine cytomegalovirus early protein CD8 T-cell epitope as an immediate early epitope based on transcription from an upstream gene.
Q35728590	Noncanonical peptides in complex with MHC class I.
Q40702974	Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells
Q47556915	Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/Kb Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome
Q27664523	Novel Immunodominant Peptide Presentation Strategy: a Featured HLA-A*2402-Restricted Cytotoxic T-Lymphocyte Epitope Stabilized by Intrachain Hydrogen Bonds from Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein
Q57011833	Novel Machine Learning Methods for MHC Class I Binding Prediction
Q38168900	Novel approaches in polyepitope T-cell vaccine development against HIV-1.
Q34401747	Novel biochemistry: post-translational protein splicing and other lessons from the school of antigen processing
Q41963641	Novel epitopes identified from efflux pumps of Mycobacterium tuberculosis could induce cytotoxic T lymphocyte response.
Q36962838	Novel immunogenic HLA-A*0201-restricted epidermal growth factor receptor-specific T-cell epitope in head and neck cancer patients
Q38789472	Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics
Q33195013	Novel strategy for identification of candidate cytotoxic T-cell epitopes from human preproinsulin
Q42326379	Nuclear export signal and immunodominant CD8+ T cell epitope in influenza A virus matrix protein 1
Q33965222	Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient.
Q51543580	OETMAP: a new feature encoding scheme for MHC class I binding prediction.
Q27005991	Ontology-supported research on vaccine efficacy, safety and integrative biological networks
Q41981083	OptiTope--a web server for the selection of an optimal set of peptides for epitope-based vaccines.
Q34558230	Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.
Q33551448	Optimization algorithms for functional deimmunization of therapeutic proteins
Q89097115	Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models
Q37239554	Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites.
Q37716789	Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes
Q43267507	Oxidative stress can alter the antigenicity of immunodominant peptides
Q64882611	PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Q34074865	POPISK: T-cell reactivity prediction using support vector machines and string kernels
Q24813312	PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse.
Q31111090	PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity
Q51926468	PREDNOD, a prediction server for peptide binding to the H-2g7 haplotype of the non-obese diabetic mouse.
Q37090212	Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods
Q36633085	Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes
Q37719552	Patented cancer vaccines: the promising leads
Q30444431	PepBank--a database of peptides based on sequence text mining and public peptide data sources
Q33934654	PeptX: using genetic algorithms to optimize peptides for MHC binding
Q33751936	Peptide binding predictions for HLA DR, DP and DQ molecules
Q37171413	Peptide epitope identification for tumor-reactive CD4 T cells
Q31097631	Peptide libraries for T cell epitope screening and characterization
Q36007167	Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors
Q30992372	Peptide vaccines and peptide libraries
Q38293525	Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer
Q38123488	Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides
Q30252926	Peptide-binding motifs of two common equine class I MHC molecules in Thoroughbred horses
Q42545343	Peptide-dependent conformational fluctuation determines the stability of the human leukocyte antigen class I complex.
Q39967522	Peptides derived from the Mycobacterium tuberculosis Rv1490 surface protein implicated in inhibition of epithelial cell entry: potential vaccine candidates?
Q37360659	Peptides presented in vivo by HLA-DR in thyroid autoimmunity.
Q37844539	Peptidomimetics: modifying peptides in the pursuit of better vaccines
Q49798727	Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes.
Q59136533	Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment
Q64236704	Perspective: The promises of a holistic view of proteins-impact on antibody engineering and drug discovery
Q42098721	Phase-dependent immune evasion of herpesviruses
Q35865440	Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations
Q34982611	Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis
Q34023384	Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1
Q58756533	Plasmodium vivax Pv12 B-cell epitopes and HLA-DRβ1*-dependent T-cell epitopes in vitro antigenicity
Q99551753	Point mutation screening of tumor neoantigens and peptide-induced specific cytotoxic T lymphocytes using The Cancer Genome Atlas database
Q51706853	Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant.
Q34235351	PolysacDB: a database of microbial polysaccharide antigens and their antibodies
Q26752532	Post-Genomics and Vaccine Improvement for Leishmania
Q59599346	Postgenomic Approaches and Bioinformatics Tools to Advance the Development of Vaccines against Bacteria of the Complex
Q45868986	Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer
Q49668436	Preclinical and clinical development of neoantigen vaccines.
Q40259551	Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-γ and IL-10.
Q33263601	Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores
Q34384277	Predicting HLA class I non-permissive amino acid residues substitutions
Q33531925	Predicting MHC class I epitopes in large datasets
Q33608371	Predicting alloreactivity in transplantation
Q33306761	Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms
Q43783758	Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A.
Q34321340	Prediction and identification of T cell epitopes in the H5N1 influenza virus nucleoprotein in chicken
Q36138983	Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins
Q40704435	Prediction and preliminary screening of HLA-A*0201-restricted epitope peptides of human GPC3.
Q58707987	Prediction of Antimicrobial Potential of a Chemically Modified Peptide From Its Tertiary Structure
Q35532615	Prediction of CD8+ Epitopes in Leishmania braziliensis Proteins Using EPIBOT: In Silico Search and In Vivo Validation
Q51442203	Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
Q42954755	Prediction of HLA-A2-restricted CTL epitope specific to HCC by SYFPEITHI combined with polynomial method
Q41807238	Prediction of MHC binding peptide using Gibbs motif sampler, weight matrix and artificial neural network
Q36274623	Prediction of MHC class I binding peptides by a query learning algorithm based on hidden markov models
Q42066174	Prediction of MHC class I binding peptides using probability distribution functions.
Q52034713	Prediction of MHC class I binding peptides using profile motifs.
Q24806545	Prediction of MHC class I binding peptides, using SVMHC
Q33289831	Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method
Q25257552	Prediction of MHC class II binding peptides based on an iterative learning model
Q42738481	Prediction of cellular immune responses against CFTR in patients with cystic fibrosis after gene therapy.
Q37806810	Prediction of epitopes using neural network based methods
Q37462980	Prediction of functional class of proteins and peptides irrespective of sequence homology by support vector machines
Q39605619	Prediction of promiscuous peptides that bind HLA class I molecules
Q43976304	Prediction of proteasome cleavage motifs by neural networks
Q33525382	Prediction of the binding affinities of peptides to class II MHC using a regularized thermodynamic model
Q35813585	Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?
Q40467039	Predictor for the effect of amino acid composition on CD4+ T cell epitopes preprocessing.
Q42220503	Preliminary exploration of HLA-A 1101-restricted human cytomegalovirus glycoprotein B-specific CD8⁺ T cells in allogeneic stem-cell transplant recipients
Q38951047	Present Yourself! By MHC Class I and MHC Class II Molecules
Q34743762	Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion
Q36978876	Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus.
Q64226743	Pro-inflammatory Cytokines Alter the Immunopeptidome Landscape by Modulation of HLA-B Expression
Q38306558	Processing sites are different in the generation of HLA-A2.1-restricted, T cell reactive tumor antigen epitopes and viral epitopes
Q98771735	Progress in Neoantigen Targeted Cancer Immunotherapies
Q27685375	Proline substitution independently enhances H-2D(b) complex stabilization and TCR recognition of melanoma-associated peptides
Q35034097	Properties of MHC class I presented peptides that enhance immunogenicity
Q78434026	Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients
Q36867296	Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model
Q53354360	Proteasomes in immune cells: more than peptide producers?
Q33727055	Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
Q43962544	Proteome-based epitopic peptide scanning along PSA.
Q24798732	Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone
Q35056736	Proximity ligation assay evaluates IDH1R132H presentation in gliomas
Q35077155	Quantitative constraints on the scope of negative selection
Q40548223	Quantitative online prediction of peptide binding to the major histocompatibility complex
Q33316579	Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries
Q30477638	Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) models
Q33349439	Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan
Q58698657	RNA editing derived epitopes function as cancer antigens to elicit immune responses
Q39627674	RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.
Q92063506	Radiation-induced small extracellular vesicles as "carriages" promote tumor antigen release and trigger antitumor immunity
Q27487800	Rapid Determination of HLA B*07 Ligands from the West Nile Virus NY99 Genome
Q33882818	Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation
Q33222048	Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.
Q52051973	Rapid epitope identification from complex class-II-restricted T-cell antigens.
Q30217177	Rapid generation of a mouse model for Middle East respiratory syndrome
Q37862710	Rapid molecular dissection of viral and bacterial immunomes
Q30844919	Rare, structurally homologous self-peptides promote thymocyte positive selection
Q48725100	Rational design of diagnostic and vaccination strategies for tuberculosis.
Q34548080	Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability.
Q28080312	Recent advances in T-cell engineering for use in immunotherapy
Q42148984	Recognition of class I MHC by a rat Ly49 NK cell receptor is dependent on the identity of the P2 anchor amino acid of bound peptide
Q24672952	Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes
Q78429536	Recovery of known T-cell epitopes by computational scanning of a viral genome
Q24307979	Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing
Q42996980	Relation of pretreatment sequence diversity in NS5A region of HCV genotype 1 with immune response between pegylated-INF/ribavirin therapy outcomes.
Q27485882	Reliable prediction of T-cell epitopes using neural networks with novel sequence representations
Q98951948	Repertoire-scale determination of class II MHC peptide binding via yeast display improves antigen prediction
Q35784865	Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy
Q40185976	Rescue of the immunotherapeutic potential of a novel T cell epitope in the Epstein-Barr virus latent membrane protein 2.
Q35149956	Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains
Q30840526	Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study
Q33444815	Retracted: Analysis of Mycobacterium tuberculosis-Specific CD8 T-Cells in Patients with Active Tuberculosis and in Individuals with Latent Infection
Q34495529	Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion
Q36471831	Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles
Q37844333	Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development
Q42582499	Rhesus macaque KIR bind human MHC class I with broad specificity and recognize HLA-C more effectively than HLA-A and HLA-B
Q37099986	Robust quantitative modeling of peptide binding affinities for MHC molecules using physical-chemical descriptors
Q40659815	Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope.
Q37107843	Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies
Q41726495	Role of peptide processing predictions in T cell epitope identification: contribution of different prediction programs.
Q34576423	Roles of heat-shock proteins in innate and adaptive immunity
Q100395455	SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Q51958531	SNEP: SNP-derived epitope prediction program for minor H antigens.
Q34547980	SVMHC: a server for prediction of MHC-binding peptides
Q33261251	SVRMHC prediction server for MHC-binding peptides
Q24651238	Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides
Q38704265	Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen
Q47148622	Scientific Opinion on the assessment of allergenicity of GM plants and microorganisms and derived food and feed
Q33770310	Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries
Q34765261	Scrutinizing MHC-I binding peptides and their limits of variation
Q30884495	Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach.
Q42248450	Selection of conserved epitopes from hepatitis C virus for pan-populational stimulation of T-cell responses.
Q36825059	Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities
Q36088409	Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion
Q38156565	Sequence analysis of T-cell repertoires in health and disease.
Q35818040	Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens
Q42118490	Sequence evolution of putative cytotoxic T cell epitopes in NS3 region of hepatitis C virus
Q28972497	Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains
Q30532816	Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds
Q40104793	Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines
Q42247561	Short peptide sequence identity between human viruses and HLA-B27-binding human 'self' peptides
Q34695369	Short-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application
Q51935955	SiPep: a system for the prediction of tissue-specific minor histocompatibility antigens.
Q27312114	Signature Patterns of MHC Diversity in Three Gombe Communities of Wild Chimpanzees Reflect Fitness in Reproduction and Immune Defense against SIVcpz
Q30009990	Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach
Q51551323	Social discrimination by quantitative assessment of immunogenetic similarity.
Q39123538	Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches
Q41325257	Soluble HLA-associated peptide from PSF1 has a cancer vaccine potency
Q34279102	Soluble plasma HLA peptidome as a potential source for cancer biomarkers
Q47840879	SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria
Q54296983	Specific CD8⁺ T cells recognize human herpesvirus 6B.
Q50654687	Specific cytotoxic T-cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells.
Q39575598	Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells
Q40794811	Stability and CTL activity of N-terminal glutamic acid containing peptides
Q34312500	State of the art and challenges in sequence based T-cell epitope prediction
Q45371304	Stepwise identification of HLA-A*0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus type 1 genome boosted by a StepRank scheme
Q82702663	Steric recognition of T-cell receptor contact residues is required to map mutant epitopes by immunoinformatical programmes
Q34165879	Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes
Q40649080	Stimulation of tumor-reactive T lymphocytes using mixtures of synthetic peptides derived from tumor-associated antigens with diverse MHC binding affinities
Q42861769	Strength in numbers: achieving greater accuracy in MHC-I binding prediction by combining the results from multiple prediction tools
Q35077813	Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection
Q30388011	Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.
Q34823910	Structural basis of immunogenicity
Q27625365	Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice
Q46941039	Structural definition of the H-2Kd peptide-binding motif
Q33786803	Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes
Q35875761	Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease
Q90290722	Structure Based Prediction of Neoantigen Immunogenicity
Q37012868	Structure and function of major histocompatibility complex class I antigens
Q40284359	Structure of the transporter associated with antigen processing trapped by herpes simplex virus
Q90735752	Structure-based Methods for Binding Mode and Binding Affinity Prediction for Peptide-MHC Complexes
Q28251858	Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies
Q39843759	Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice
Q47133530	Synthetic peptides mimicking lipopolysaccharide as a potential vaccine candidates against Vibrio cholerae serogroup O1.
Q33510342	Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands
Q58587953	Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes
Q26782580	Systems Biology Approach for Cancer Vaccine Development and Evaluation
Q38207141	Systems vaccinology for cancer vaccine development
Q42648564	T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry
Q35143307	T cell epitope identification for bovine vaccines: an epitope mapping method for BoLA A-11.
Q33965405	T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts.
Q26787014	T cell epitopes and post-translationally modified epitopes in type 1 diabetes
Q47582356	T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer
Q34120055	T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice
Q45364496	T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
Q21559508	T cell responses to human endogenous retroviruses in HIV-1 infection
Q36210864	T cell-mediated immunotherapy of metastases: state of the art in 2005.
Q39628181	T cells reactive with HLA-A*0201 peptides from the histone demethylase JARID1B are found in the circulation of breast cancer patients
Q73006409	T- and B-cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice
Q37575359	T-cell epitope mapping
Q35918501	T-cell epitope peptide vaccines.
Q30486286	T-cell epitope prediction: rescaling can mask biological variation between MHC molecules
Q36702419	T-cell epitope vaccine design by immunoinformatics
Q34151667	T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.
Q38871209	T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors
Q38372371	TANTIGEN: a comprehensive database of tumor T cell antigens
Q35377746	TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes.
Q28481206	TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules
Q35063474	Tapasin discriminates peptide-human leukocyte antigen-A*02:01 complexes formed with natural ligands
Q39595809	Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.
Q39026731	Targeting high-grade B cell lymphoma with CD19-specific T cells
Q39149196	Targeting neoantigens to augment antitumour immunity
Q38863894	Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.
Q37363754	Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation
Q90232644	Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine
Q56897975	Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability
Q36745749	Telomerase immunity from bench to bedside: round one.
Q41827687	TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates
Q40454951	Testing the role of gp96 as peptide chaperone in antigen processing.
Q35948350	Textmining in support of knowledge discovery for vaccine development
Q39145269	The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity
Q61910266	The CD68 protein as a potential target for leukaemia-reactive CTL
Q35745162	The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study
Q35105393	The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection
Q38301380	The HLA-A0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A0206.
Q30400430	The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
Q42317060	The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.
Q36509857	The MHC class I peptide repertoire is molded by the transcriptome.
Q38663365	The Role of Multiscale Protein Dynamics in Antigen Presentation and T Lymphocyte Recognition
Q38753386	The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer
Q34146229	The SSX family of cancer-testis antigens as target proteins for tumor therapy
Q34324298	The Trypanosoma cruzi flagellum is discarded via asymmetric cell division following invasion and provides early targets for protective CD8⁺ T cells
Q30444065	The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes
Q42994117	The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients
Q39814591	The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptides.
Q39422790	The development of Chinese specific human cytomegalovirus polyepitope recombinant vaccine
Q38818906	The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis
Q39084138	The elucidation of non-classical MHC class II antigen processing through the study of viral antigens
Q38062377	The epitopes in wheat proteins for defining toxic units relevant to human health
Q47569740	The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
Q51987808	The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cells.
Q37848454	The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept
Q24296246	The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A3101 and -A3303
Q39182194	The human leukocyte antigen-presented ligandome of B lymphocytes
Q34288498	The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins
Q39090059	The immunogenicity of a novel cytotoxic T lymphocyte epitope from tumor antigen PL2L60 could be enhanced by 4-chlorophenylalanine substitution at position 1.
Q36927645	The immunoinformatics of cancer immunotherapy
Q36457849	The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma
Q27664962	The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family
Q50113126	The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in Rheumatoid Arthritis.
Q36291919	The role of computational models of the immune system in designing vaccination strategies
Q47190955	The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction
Q40895891	The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules
Q56879701	The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage
Q33221191	The sentinel within: exploiting the immune system for cancer biomarkers
Q33264233	The separate and combined effects of MHC genotype, parasite clone, and host gender on the course of malaria in mice
Q46396844	The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture's disease.
Q38915023	The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus
Q36031220	The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response
Q35826752	Therapeutic Vaccine Strategies against Human Papillomavirus
Q35193892	Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept
Q36948849	Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma
Q35604228	Therapeutic vaccination for chronic diseases: a new class of drugs in sight
Q37208000	Thermodynamics of Peptide-MHC Class II Interactions: Not all Complexes are Created Equal
Q35784696	Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection
Q38161480	Tools and methods for identification and analysis of rare antigen-specific T lymphocytes.
Q38650013	Tools to define the melanoma-associated immunopeptidome.
Q36762526	Toward a multiscale model of antigen presentation in immunity
Q37939072	Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools.
Q38088325	Towards in silico design of epitope-based vaccines
Q96641056	Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
Q35005960	Towards patient-specific tumor antigen selection for vaccination
Q55640745	Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target Selection.
Q41828121	Translation from the 5' untranslated region shapes the integrated stress response
Q36685319	Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules
Q52619024	Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
Q28483146	Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine
Q35160569	Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides
Q28082704	Tumor neoantigens: building a framework for personalized cancer immunotherapy
Q35671699	Tumor vaccines.
Q89965816	Tumor-Specific T Cell Activation in Malignant Brain Tumors
Q33459720	Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B08 and HLA-B2705, bind peptides with sequence similarity
Q34224580	Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides
Q36134088	Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysis
Q38787035	Unmasking targets of antitumor immunity via high-throughput antigen profiling
Q30391717	Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions
Q39639898	Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells
Q40048119	Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices
Q34973081	Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice
Q57537584	Use of Bioinformatics to Predict MHC Ligands and T-Cell Epitopes
Q57537680	Use of bioinformatics to predict MHC ligands and T-cell epitopes: Application to epitope-driven vaccine design
Q34815630	Use of class II tetramers for identification of CD4+ T cells
Q34782568	Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response
Q30599291	Using databases and data mining in vaccinology
Q35031973	Using the World Wide Web for predicting CTL epitopes
Q36605186	Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy
Q36565705	Vaccination using peptides spanning the SYT-SSX tumor-specific translocation
Q45324559	Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection
Q34194709	Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection
Q35218994	Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.
Q21089599	Vaccines: from empirical development to rational design
Q37089515	Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans
Q42730634	Vaccinomics Approach for Designing Potential Peptide Vaccine by Targeting Shigella spp. Serine Protease Autotransporter Subfamily Protein SigA
Q36553635	Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans
Q21328677	Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development
Q39791206	Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses.
Q35665799	Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.
Q57063675	Viral bioinformatics
Q39860756	Viral fitness implications of variation within an immunodominant CD8+ T-cell epitope of HIV-1.
Q42989673	Virological and epitope evolution of HCV infection from acute hepatitis C to subsequent episodes of HCV-related acute liver cell necrosis
Q37206378	Viruses selectively mutate their CD8+ T-cell epitopes--a large-scale immunomic analysis
Q34137664	Whole genomes of Chandipura virus isolates and comparative analysis with other rhabdoviruses
Q33916280	Whole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response
Q36047531	ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes
Q35837827	Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?
Q85076205	[Prostate carcinoma: vaccination as a new option for treatment]
Q89850600	dbPepNeo: a manually curated database for human tumor neoantigen peptides
Q30157638	iSPOT: a web tool for the analysis and recognition of protein domain specificity
Q37202382	sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides
Q45875096	ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum

scholarly article	Q13442814
review article	Q7318358

P6179	Dimensions Publication ID	1019170092
P356	DOI	10.1007/S002510050595
P3181	OpenCitations bibliographic resource ID	915730
P698	PubMed publication ID	10602881

P2093	author name string	Bachmann J
		Stevanović S
		Bachor OA
		Emmerich NP
		Rammensee H
P433	issue	3-4
P407	language of work or name	English	Q1860
P921	main subject	database	Q8513
P304	page(s)	213-9
P577	publication date	1999-11-01
P1433	published in	Immunogenetics	Q15709984
P1476	title	SYFPEITHI: database for MHC ligands and peptide motifs
P478	volume	50

SYFPEITHI: database for MHC ligands and peptide motifs

scientific article (publication date: November 1999)

Reverse relations